Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Ocugen Stock Is Skyrocketing Today

TheMotleyFool

0 0

Shares of Ocugen (NASDAQ: OCGN) had skyrocketed by 19.1% as of 11:15 a.m. ET on Tuesday. The huge gain came after the company announced that the Food and Drug Administration (FDA) had lifted the clinical hold on its investigational new drug (IND) application for COVID-19 vaccine Covaxin.

Ocugen's announcement came after the market closed on Friday. Since the stock market was closed on Monday for Presidents' Day, investors had to wait for the biotech stock to soar.

The FDA initially placed a clinical hold on Ocugen's IND in November. As a result, Ocugen wasn't able to begin its planned phase 3 study of Covaxin in the U.S.

Source Fool.com

Like: 0

OCGN

Share